Association of serum potassium concentration with mortality and ventricular arrhythmias in patients with acute myocardial infarction: A systematic review and meta-analysis

Abstract

Background

Challenging clinical practice guidelines that recommend serum potassium concentration between 4.0–5.0 mEq/L or ≥4.5 mEq/L in patients with acute myocardial infarction, recent studies found increased mortality risks in patients with a serum potassium concentration of ≥4.5 mEq/L. Studies investigating consequences of hypokalemia after acute myocardial infarction revealed conflicting results. Therefore, the aim of this systematic review and meta-analysis was to combine evidence from previous studies on the association of serum potassium concentration with both short and long-term mortality as well as the occurrence of ventricular arrhythmias.

Design

Systematic review and meta-analysis.

Methods

A structured search of MEDLINE and EMBASE databases yielded 23 articles published between 1990 and January 2017 that met the inclusion criteria. Study selection, data extraction and quality assessment were carried out by three reviewers. Random effects models were used to pool estimates across the included studies and sensitivity analyses were performed when possible.

Results

Twelve studies were included in the meta-analysis. Both pooled results from six studies investigating short-term mortality and from five studies examining long-term mortality revealed significantly increased risks in patients with serum potassium concentrations of <3.5 mEq/L, 4.5–<5.0 mEq/L and ≥5.0 mEq/L after acute myocardial infarction. In addition, a serum potassium concentration of <3.5 mEq/L was significantly associated with the occurrence of ventricular arrhythmias.

Conclusions

Mortality, both short and long term, and the occurrence of ventricular arrhythmias in patients with acute myocardial infarction seem to be negatively associated with hypokalemic serum potassium concentration. There is evidence for adverse consequences of serum potassium concentrations of ≥4.5 mEq/L. Due to the heterogeneity among existing studies, further research is necessary to confirm the need to change clinical practice guidelines.

Keywords

Myocardial infarction hypokalemia hyperkalemia mortality arrhythmia meta-analysis

Get full access to this article

View all access options for this article.

References

Schaefer

Wolford

. Disorders of potassium. Emerg Med Clin North Am 2005; 23: 723–747, viii–ix.

Clausen

. Hormonal and pharmacological modification of plasma potassium homeostasis. Fundam Clin Pharmacol 2010; 24: 595–605.

Alfonzo

Isles

Geddes

et al.

Potassium disorders – clinical spectrum and emergency management. Resuscitation 2006; 70: 10–25.

Heerspink

Gao

de Zeeuw

et al.

The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial. Eur J Prev Cardiol 2014; 21: 299–309.

Cohn

Kowey

Whelton

et al.

New guidelines for potassium replacement in clinical practice: a contemporary review by the National Council on Potassium in Clinical Practice. Arch Intern Med 2000; 160: 2429–2436.

Zipes

Camm

Borggrefe

et al.

ACC/AHA/ESC 2006 Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006; 8: 746–837.

Antman

Anbe

Armstrong

et al.

ACC/AHA Guidelines for the management of patients with ST-elevation myocardial infarction – executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol 2004; 44: 671–719.

Macdonald

Struthers

. What is the optimal serum potassium level in cardiovascular patients? J Am Coll Cardiol 2004; 43: 155–161.

Goyal

Spertus

Gosch

et al.

Serum potassium levels and mortality in acute myocardial infarction. JAMA 2012; 307: 157–164.

10.

Choi

Kim

et al.

Relation of serum potassium level to long-term outcomes in patients with acute myocardial infarction. Am J Cardiol 2014; 113: 1285–1290.

11.

Shiyovich

Gilutz

Plakht

. Serum potassium levels and long-term post-discharge mortality in acute myocardial infarction. Int J Cardiol 2014; 172: e368–e370.

12.

Fiol Sala

M IJJ

Benito Vales

Gutierrez Marti

et al.

Hipocaliemia y fibrilacion ventricualar primaria en pacientes con infarcto agudo de miocardio. Med Intentiva 1993; 17: 276–279.

13.

Madias

Shah

Chintalapally

et al.

Admission serum potassium in patients with acute myocardial infarction: its correlates and value as a determinant of in-hospital outcome. Chest 2000; 118: 904–913.

14.

Pourmoghaddas

Shemirani

Garakyaraghi

. Association of serum potassium level with ventricular tachycardia after acute myocardial infarction. ARYA Atheroscler 2012; 8: 79–81.

15.

Patel

Tannenbaum

Viana-Tejedor

et al.

Serum potassium levels, cardiac arrhythmias, and mortality following non-ST-elevation myocardial infarction or unstable angina: insights from MERLIN-TIMI 36. Eur Heart J Acute Cardiovasc Care 2015; 6: 18–25.

16.

Uluganyan

Ekmekci

Murat

et al.

Admission serum potassium level is associated with in-hospital and long-term mortality in ST-elevation myocardial infarction. Anatol J Cardiol 2016; 16: 10–15.

17.

Ognibene

Ciniglio

Greifenstein

et al.

Ventricular tachycardia in acute myocardial infarction: the role of hypophosphatemia. South Med J 1994; 87: 65–69.

18.

Krijthe

Heeringa

Kors

et al.

Serum potassium levels and the risk of atrial fibrillation: the Rotterdam Study. Int J Cardiol 2013; 168: 5411–5415.

19.

Liang

Zhu

et al.

Serum potassium levels and short-term outcomes in patients with ST-segment elevation myocardial infarction. Angiology 2016; 67: 729–736.

20.

Moher

Liberati

Tetzlaff

et al. The PRISMA Group . Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA Statement. PLoS Med 2009; 6: e1000097–e1000097.

21.

Downs

Black

. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Commun Health 1998; 52: 377–384.

22.

Higgins

Altman

Gotzsche

et al.

The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 2011; 343: d5928–d5928.

23.

Borenstein

Hedges

Higgins

JPT

et al.

Software, in Introduction to Meta-Analysis, Chichester, UK: John Wiley & Sons Ltd., 2009.

24.

Higgins JPT and Green S. Cochrane Handbook for Systematic Reviews of Interventions, version 5.1.0 (updated March 2011) The Cochrane Collaboration, 2011. www.handbook.cochrane.org (accessed 1 June 2017).

25.

Verma

Agarwal

Sharma

et al.

Dyselectrolytaemia in acute myocardial infarction. JIACM 2015; 16: 201–203.

26.

Kiranmai

. Serial estimation of serum magnesium, calcium, sodium and potassium levels in myocardial infarction. Int J Pharm Bio Sci 2013; 4: 1190–1195.

27.

Lettieri

Chiefari

Nespoli

et al.

[Hypomagnesemia and hypokalemia as risk factors of arrhythmia in acute phase myocardial infarction]. Minerva Anestesiol 1991; 57: 335–339.

28.

Keskin

Kaya

Tatlisu

et al.

The effect of serum potassium level on in-hospital and long-term mortality in ST elevation myocardial infarction. Int J Cardiol 2016; 221: 505–510.

29.

Grodzinsky

Goyal

Gosch

et al.

Prevalence and prognosis of hyperkalemia in patients with acute myocardial infarction. Am J Med 2016; 129: 858–865.

30.

Shlomai

Berkovitch

Pinchevski-Kadir

et al.

The association between normal-range admission potassium levels in Israeli patients with acute coronary syndrome and early and late outcomes. Medicine (Baltimore) 2016; 95: e3778–e3778.

31.

Huang

. Lower mean corpuscular hemoglobin concentration is associated with poorer outcomes in intensive care unit admitted patients with acute myocardial infarction. Ann Transl Med 2016; 4: 190–190.

32.

Tian

et al.

Additional predictive value of serum potassium to thrombolysis in myocardial infarction risk score for early malignant ventricular arrhythmias in patients with acute myocardial infarction. Am J Emerg Med 2012; 30: 1089–1094.

33.

Nicolaou

Papadakis

Chrysohoou

et al.

The prognostic significance of serum glucose levels after the onset of ventricular arrhythmia on in-hospital mortality of patients with acute coronary syndrome. Rev Diabet Stud 2008; 5: 47–51.

34.

Maciejewski

Bednarz

Chamiec

et al.

Acute coronary syndrome: potassium, magnesium and cardiac arrhythmia. Kardiol Pol 2003; 59: 402–407.

35.

Pohl

Mory

Nurnberg

et al.

[Serum magnesium, serum potassium and arrhythmia profile in patients with acute myocardial infarct]. Wien Klin Wochenschr 1993; 105: 163–166.

36.

Friedensohn

Faibel

Bairey

et al.

Malignant arrhythmias in relation to values of serum potassium in patients with acute myocardial infarction. Int J Cardiol 1991; 32: 331–338.

37.

Higham

Adams

Murray

et al.

Plasma potassium, serum magnesium and ventricular fibrillation: a prospective study. Q J Med 1993; 86: 609–617.

38.

Gettes

. Electrolyte abnormalities underlying lethal and ventricular arrhythmias. Circulation 1992; 85: I70–I76.

39.

Podrid

. Potassium and ventricular arrhythmias. Am J Cardiol 1990; 65: 33E–44E; discussion 52E.

40.

Bae

Lim

Cho

et al.

GFR and cardiovascular outcomes after acute myocardial infarction: results from the Korea Acute Myocardial Infarction Registry. Am J Kidney Dis 2012; 59: 795–802.

41.

Traub

Rabinov

Rosenfeld

et al.

Elevation of serum potassium during beta blockade: absence of relationship to the renin-aldosterone system. Clin Pharmacol Ther 1980; 28: 765–768.

42.

Johansson

Dziamski

. Malignant arrhythmias in acute myocardial infarction. Relationship to serum potassium and effect of selective and non-selective beta-blockade. Drugs 1984; 28(Suppl 1): 77–85.

43.

Goldberg

Yarzebski

Spencer

et al.

Thirty-year trends (1975–2005) in the magnitude, patient characteristics, and hospital outcomes of patients with acute myocardial infarction complicated by ventricular fibrillation. Am J Cardiol 2008; 102: 1595–1601.

44.

Avezum

Piegas

Goldberg

et al.

Magnitude and prognosis associated with ventricular arrhythmias in patients hospitalized with acute coronary syndromes (from the GRACE Registry). Am J Cardiol 2008; 102: 1577–1582.

45.

Osadchii

. Mechanisms of hypokalemia-induced ventricular arrhythmogenicity. Fundam Clin Pharmacol 2010; 24: 547–559.

46.

Gennari

. Hypokalemia. N Engl J Med 1998; 339: 451–458.

47.

Crop

Hoorn

Lindemans

et al.

Hypokalaemia and subsequent hyperkalaemia in hospitalized patients. Nephrol Dial Transplant 2007; 22: 3471–3477.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.47 MB